Vimovo

Horizon Therapeutics USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 25, 2023
Approval ID: baa47781-7151-4c75-a9a2-d2eac0a7d55e
Products: 2 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VIMOVO safely and effectively. See full prescribing information for VIMOVO. VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets, for oral use Initial U.S. Approval: 2010

Quick Stats

Total Products2

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.